To achieve this, we utilized siRNA transfection to knock down NLRP4 and NLRP5 in the liver cancer cell lines HCCLM3 and HepG2, and subsequently confirmed the knockdown efficiency through RT-qPCR analysis (Fig. 6B,C). The gene discussed is NLRP5; the disease is liver cancer.